07:05 AM EDT, 10/02/2024 (MT Newswires) -- Genenta Science (GNTA) said Wednesday it received approval from the Italian Medicines Agency for a phase 1 clinical trial evaluating the company's drug Temferon in treating metastatic renal cell cancer. The trial is expected to commence in Q4, Genenta said. It will target patients with a median overall survival that is currently less...

07:08 AM EDT, 10/02/2024 (MT Newswires) -- Vera Therapeutics ( VERA ) said Wednesday that it would expand the development of its lead asset, atacicept, following positive results from the ongoing phase 2 and 3 trials in patients with IgA nephropathy and other autoimmune kidney indications. The company said it plans to initiate a study in Q4 to give its...

* Canary Wharf mulling approaches from 30-plus hotel operators * Close to deal with 74-bed boutique hotel * Landlord has faced tough time, with falling office demand (Adds office vacancy data in paragraph 3, graphic) By Iain Withers LONDON, Oct 2 (Reuters) - London's Canary Wharf financial district wants to convert swathes of empty office space into other uses including...

(Reuters) - A U.S. Federal Trade Commission official said on Wednesday that the country's leading seafood restaurant chains have been warned that the agency will crack down on false claims of locally caught fare, following complaints from the domestic fishing industry of misleading menus and advertising. The U.S. imports about 80% of its seafood, according to the National Oceanic and...